Recent OCX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:08:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:05:19 PM
- Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 • GlobeNewswire Inc. • 11/06/2024 09:45:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/22/2024 08:12:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/22/2024 04:15:12 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/18/2024 08:55:04 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/16/2024 09:16:51 PM
- Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles • GlobeNewswire Inc. • 10/16/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:22:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 08:15:18 PM
- Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 11:40:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 10:05:29 AM
- Oncocyte Signs Leading Transplant Centers in US and Germany • GlobeNewswire Inc. • 10/02/2024 10:41:25 PM
- Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 10/02/2024 10:35:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/25/2024 08:09:08 PM
- PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology • GlobeNewswire Inc. • 08/20/2024 01:00:00 PM
- Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study • GlobeNewswire Inc. • 08/12/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 10:37:23 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 10:25:21 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:27:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:22 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM